DAN
Dana Incorporated
DAN has the edge over LCID overall, supported by stronger valuation and stronger modeled upside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
DAN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Stable |
DAN's profitability is currently healthy, and its revenue and balance sheet are stable, but its cash flow is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.4x | $23.26 | — |
| Cheap | 5.9x | $56.02 | +141% |
| Forward | 6.6x | $23.26 | — |
| Fair | 16x | $152 | +553% |
| Expensive | 53x | $506 | +2075% |
Historical ranges are pointers, not guarantees.
DAN's PE is in its cheap range at 2.4x. On analysts' estimates for next year's earnings, today's price would be 6.6x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
DAN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DAN, with profitability holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.54 | -63% |
| Q3 2026 | $9.55 | +2022% |
| Q2 2026 | $10.05 | +$10.21 |
| Q1 2026 | $10.29 | +$10.53 |
| Q4 2025 | $0.57 | +$0.96 |
| Q3 2025 | $0.45 | +$0.56 |
| Q2 2025 | -$0.16 | -$0.15 |
| Q1 2025 | -$0.24 | -367% |
| Q4 2024 | -$0.39 | -250% |
DAN has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
DAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +6.3% |
| Q2 2026 | $2B | +3.9% |
| Q1 2026 | $1.9B | -21% |
| Q4 2025 | $1.9B | -20% |
| Q3 2025 | $1.9B | -23% |
| Q2 2025 | $1.9B | -29% |
| Q1 2025 | $2.4B | -14% |
| Q4 2024 | $2.3B | -6.4% |
DAN's revenue is recovering but still below its 2023 peak: $2B last quarter, up 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | +1.8 points |
| Q2 2026 | 3.8% | +2.9 points |
| Q1 2026 | 1% | -2 points |
| Q4 2025 | 3.3% | +4.9 points |
| Q3 2025 | 2.8% | -0.8 points |
| Q2 2025 | 0.8% | -3 points |
| Q1 2025 | 3.1% | +0.5 points |
| Q4 2024 | -1.5% | -2 points |
DAN has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over DAN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
DAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32M | -48% |
| Q2 2026 | -$33M | -1200% |
| Q1 2026 | -$257M | -$145M |
| Q4 2025 | $345M | +132% |
| Q3 2025 | $62M | +$73M |
| Q2 2025 | $3M | -97% |
| Q1 2025 | -$112M | +$60M |
| Q4 2024 | $149M | +9.6% |
DAN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
DAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.7% | -4M shares |
| 1 year | -19% | -25.3M shares |
| 3 years | -27% | -39.2M shares |
| 5 years | -28% | -40.7M shares |
| Available history | -27% | -39.6M shares |
DAN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $200M |
| Q2 2026 | $44M |
| Q1 2026 | $125M |
| Q4 2025 | $211M |
| Q3 2025 | $182M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
DAN spent $580M buying back its own shares over the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
DAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 4.8x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.3x | Elevated |
DAN's net debt is about 2.1 years of its operating earnings (EBITDA), down from 5.7 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 7.3 | Oversold |
DAN's weekly RSI is 39 (neutral) and its Stochastic is 7 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DAN PE vs Consumer Cyclical Sector
| Metric | DAN | Sector median | Relative |
|---|---|---|---|
| PE | 2.4x | 18x | 86% below |
| PE % | 2 | 47 | 45 pts below |
DAN is trading at 2.4x earnings, a 86% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
DAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 11% below |
| 20 week MA | $27.7 | 16% below |
| 50 week MA | $29.8 | 22% below |
| 100 week MA | $23.2 | 0.4% above |
| 200 week MA | $18.3 | 27% above |
DAN has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
DAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.4 | $19.6 | +6.7% |
| 2021 | $19.6 | $22.5 | +15% |
| 2022 | $22.5 | $14.9 | -34% |
| 2023 | $14.9 | $14.6 | -2.1% |
| 2024 | $14.6 | $11.7 | -20% |
| 2025 | $11.7 | $23.9 | +104% |
| 2026 YTD | $23.9 | $23.3 | -2.6% |
DAN has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.